Literature DB >> 6130293

Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis.

C R Hind, H Paraskevakou, C M Lockwood, D J Evans, D K Peters, A J Rees.   

Abstract

48 patients with rapidly progressive glomerulonephritis were treated by a regimen of intensive plasma exchange, steroids, and cytotoxic drugs. All required dialysis before immunosuppressive treatment was started, and all had 50% or more of their glomeruli affected by crescent formation. Renal function was not recovered in any of the 21 patients with anti-glomerular basement membrane antibody disease. In contrast 63% of patients without these autoantibodies recovered renal function. Plasma creatinine remained stable over prolonged follow-up (6-60 months) in all but 1 of the 10 late survivors. There was no correlation between the extent of crescent formation and recovery of renal function in those patients without circulating anti-glomerular basement membrane antibodies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6130293     DOI: 10.1016/s0140-6736(83)91685-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Combination therapy in autoimmune disease: vasculitis.

Authors:  D Carruthers; P Bacon
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Pulmonary haemorrhage in Henoch-Schonlein purpura.

Authors:  D Veale; M C Venning; A Quinn
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139

3.  Chronic renal failure associated with topical application of paraphenylenediamine.

Authors:  J S Savill; A J Rees
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-07

Review 4.  Renal vasculitis: a review.

Authors:  G Neild
Journal:  J R Soc Med       Date:  1985-08       Impact factor: 5.344

5.  Objective monitoring of disease activity in polyarteritis by measurement of serum C reactive protein concentration.

Authors:  C R Hind; C O Savage; C G Winearls; M B Pepys
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07

6.  Vasculitis and rapidly progressive glomerulonephritis in the elderly.

Authors:  R M Higgins; D J Goldsmith; J Connolly; J E Scoble; B M Hendry; P Ackrill; M C Venning
Journal:  Postgrad Med J       Date:  1996-01       Impact factor: 2.401

7.  Impact of clinical and histopathological factors on outcome of Egyptian patients with crescentic glomerulonephritis.

Authors:  A A El-Husseini; A E El-Agroudy; F E Moustafa; M A Fouda; M A Sobh
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 8.  The treatment of glomerulonephritis in children.

Authors:  G B Haycock
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

Review 9.  Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis.

Authors:  Sofia Lionaki; J Charles Jennette; Ronald J Falk
Journal:  Semin Immunopathol       Date:  2007-10-18       Impact factor: 9.623

10.  Pulmonary haemorrhage complicating Wegener's granulomatosis and microscopic polyarteritis.

Authors:  S J Haworth; C O Savage; D Carr; J M Hughes; A J Rees
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.